Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications
Abstract
Innate lymphoid cells (ILC) represent a group of lymphocytes that lack specific antigen receptors and are relatively rare as compared to adaptive lymphocytes. ILCs play important roles in allergic and nonallergic inflammatory diseases due to their location at barrier surfaces within the airways, gut, and skin, and they respond to cytokines produced by activated cells in their local environment. Innate lymphoid cells contribute to the immune response by the release of cytokines and other mediators, forming a link between innate and adaptive immunity. In recent years, these cells have been extensively characterized and their role in animal models of disease has been investigated. Data to translate the relevance of ILCs in human pathology, and the potential role of ILCs in diagnosis, as biomarkers and/or as future treatment targets are also emerging. This review, produced by a task force of the Immunology Section of the European Academy of Allergy and Clinical Immunology (EAACI), encompassing clinicians and researchers, highlights the role of ILCs in human allergic and nonallergic diseases in the airways, gastrointestinal tract, and skin, with a focus on new insights into clinical implications, therapeutic options, and future research opportunities.Keywords
Funding Information
- European Academy of Allergy and Clinical Immunology
This publication has 119 references indexed in Scilit:
- Sputum cytokine mapping reveals an ‘IL‐5, IL‐17A, IL‐25‐high’ pattern associated with poorly controlled asthmaClinical & Experimental Allergy, 2013
- TSLP Elicits IL-33–Independent Innate Lymphoid Cell Responses to Promote Skin InflammationScience Translational Medicine, 2013
- Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunityNature Immunology, 2011
- IL-23–responsive innate lymphoid cells are increased in inflammatory bowel diseaseJournal of Experimental Medicine, 2011
- Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patientsRespiratory Research, 2010
- A Large-Scale, Consortium-Based Genomewide Association Study of AsthmaNew England Journal of Medicine, 2010
- Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependentJournal of Experimental Medicine, 2010
- PsoriasisNew England Journal of Medicine, 2009
- Airway Lipoxin A4 Generation and Lipoxin A4 Receptor Expression Are Decreased in Severe AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Immunology of asthma and chronic obstructive pulmonary diseaseNature Reviews Immunology, 2008